drugset / Trial / NCT04451239
Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis
NaSingle-groupOpen-labelTreatment
Summary
To explore the feasibility of combined topical corticosteroid and topical cyclosporine-A in COVID-19 patients with acute keratoconjunctivitis.
Timeline
- Start
- 2020-06-30
- Primary completion
- 2020-07
- Completion
- 2020-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 0.5 % | Topical |
| Subject | Prednisolone | Other / unclassified | 1 % | Topical |